Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
Abbott officially wants out of its $5.8 billion merger with Alere. Last week, the Illinois-based diagnostics giant asked a Delaware Chancery Court to…
From - Laboratory Industry Report
The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. Here is a look at…
From - Laboratory Industry Report
The Centers for Medicare and Medicaid Services (CMS) recently published final rules on reimbursement under the…